4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-19-000257
Options or other derivatives
- Pres. Diagnostics & Genom acquired 30,272 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kelderman Kim · Pres. Diagnostics & Genom
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-08-07 | Grant or award : show line 1 in the form Restricted Stock Units | +2,363 | 2,363 | D |
| 2019-08-07 | Grant or award : show line 2 in the form Stock Options (Right to Buy) | +11,961 | 11,961 | D |
| 2019-08-07 | Grant or award : show line 3 in the form Stock Options (Right to Buy) | +15,948 | 15,948 | D |
Loading xslF345X03/edgar.xml…